Search results
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 11 hours agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented ...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 3 days agoModerna's vaccine was approved for the prevention of RSV-associated lower respiratory tract disease...
Is Moderna Stock a Buy Now That It's a 2-Product Company? | The Motley Fool
The Motley Fool· 13 hours agoThe shortened trading week that ended on May 31 was a strange one for the vaccine developer Moderna...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 3 days agoThe cancer vaccine reduced the likelihood cancer would return or patients would die by 49% after...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 3 days agoThe shot was also 68.4% effective against acute respiratory disease. William Blair...recipients of...
Moderna's RSV vaccine for older adults approved
Axios· 3 days agoWhy it matters: It's Moderna's second approved product, and company officials said it's the first mRNA vaccine approved for a disease other than COVID-19...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 4 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
FDA Approves First mRNA RSV Vaccine
MedPage Today· 4 days agoThe vaccine will be Moderna's second marketed product, in addition to its SARS-CoV-2 mRNA-1273 vaccine (Spikevax). The FDA's approval ...
The chicken and egg problem of fighting another flu pandemic
Salon.com· 3 days ago“It’s almost comical to be using a 1940s technology for a 21st-century pandemic,” said Rick Bright,...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
